Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 992
Filter
1.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 49(5): 818-824, 2024 May 28.
Article in English, Chinese | MEDLINE | ID: mdl-39174896

ABSTRACT

Actinomycosis is a rare chronic granulomatous disease characterized by granuloma formation and tissue fibrosis with sinus tracts, often misdiagnosed due to its similarity to many infectious and non-infectious diseases. This report presents a case of a 60-year-old female with more than 10 years history of rheumatoid arthritis who developed actinomycosis infection after long-term treatment with immunosuppressants and biologics, including methotrexate, leflunomide, and infliximab, leading to recurrent joint pain, poorly controlled rheumatoid arthritis activity, and persistent elevation of white blood cell counts. Abdominal CT revealed a pelvic mass and right ureteral dilation. Pathological examination of cervical tissue showed significant neutrophil infiltration and sulfur granules, indicating actinomycosis. The patient received 18 months of doxycycline treatment for the infection and continued rheumatoid arthritis therapy with leflunomide, hydroxychloroquine sulfate, and tofacitinib, resulting in improved joint symptoms and normalized white blood cell counts. After 2 years of follow-up, the patient remained stable with no recurrence. This case highlights the importance of clinicians being vigilant for infections, particularly chronic, occult infections from rare pathogens, in rheumatoid arthritis patients on potent immunosuppressants and biologics, advocating for early screening and diagnosis.


Subject(s)
Actinomycosis , Arthritis, Rheumatoid , Ureteral Obstruction , Humans , Female , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/drug therapy , Middle Aged , Actinomycosis/diagnosis , Actinomycosis/complications , Actinomycosis/drug therapy , Ureteral Obstruction/etiology , Immunosuppressive Agents/therapeutic use
2.
Medicina (Kaunas) ; 60(7)2024 Jul 19.
Article in English | MEDLINE | ID: mdl-39064601

ABSTRACT

Actinomycosis is a rare infectious disease characterized by slowly progressive, chronic suppurative lesions, often mistaken for malignancies due to its ability to mimic them. It is caused by Actinomyces bacteria, which are part of the normal flora of the human oropharynx, gastrointestinal, and urogenital tracts. This case report describes a 51-year-old male with a history of mandibular rhabdomyosarcoma presenting with severe shoulder and hip pain, dysphagia, and headaches, initially suspected to be a cancer recurrence. However, after further investigation, including a PET-CT and tonsillectomy, the diagnosis of actinomycosis was confirmed through histopathological examination. The case highlights the diagnostic challenges of actinomycosis, especially in patients with complex clinical histories, emphasizing the importance of considering it as a differential diagnosis in similar presentations. The patient was treated with long-term antibiotic therapy, predominantly beta-lactams, demonstrating the necessity of a comprehensive diagnostic approach and the implications of a delayed diagnosis. This case underscores the critical need for high clinical suspicion and awareness among healthcare professionals regarding the potential for actinomycosis to mimic more common diseases, ensuring timely and accurate treatment.


Subject(s)
Actinomycosis , Rhabdomyosarcoma , Humans , Male , Middle Aged , Actinomycosis/diagnosis , Actinomycosis/drug therapy , Diagnosis, Differential , Rhabdomyosarcoma/diagnosis , Anti-Bacterial Agents/therapeutic use , Palatine Tonsil/microbiology
3.
BMJ Case Rep ; 17(6)2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38890117

ABSTRACT

Actinomycosis is a rare endogenous infection characterised by indolent progression, contiguous spreading, abscess formation and draining sinuses. Here, we present a case of Schaalia odontolytica causing a mediastinal abscess that is unique in its acuity and location. Our patient presented with worsening dysphagia, and CT of her chest revealed a new mass in the posterior mediastinum displacing the oesophagus. Oesophagram revealed mild motility disorder, but no masses or ulcers within the oesophagus. Oesophagogastroduodenoscopy with endoscopic ultrasound revealed extrinsic compression of the oesophagus. Fine-needle aspiration of the mass yielded purulent fluid, which was cultured. A single colony of S. odontolytica was isolated. Initially, medical treatment was favoured, but as she developed worsening dysphagia, the abscess was drained. She continued on long-term antibiotic therapy after drainage and had complete resolution of the abscess at 1 year.


Subject(s)
Actinomycosis , Deglutition Disorders , Immunocompromised Host , Mediastinal Diseases , Humans , Female , Actinomycosis/diagnosis , Actinomycosis/complications , Actinomycosis/drug therapy , Deglutition Disorders/etiology , Mediastinal Diseases/diagnosis , Diagnosis, Differential , Abscess/diagnosis , Abscess/microbiology , Anti-Bacterial Agents/therapeutic use , Tomography, X-Ray Computed , Drainage , Middle Aged , Mediastinum
4.
Przegl Epidemiol ; 78(1): 16-21, 2024 Jun 07.
Article in English, Polish | MEDLINE | ID: mdl-38904308

ABSTRACT

Actinomycosis is a very rare, infectious disease, which is especially difficult to diagnose due to non-specific symptoms and the ability to emulate neoplasms or inflammatory changes. Due to those facts, it is often misdiagnosed or diagnosed too late to be successfully treated. This article presents the case of 31-year-old Caucasian female with recurrent upper respiratory tract infections and tonsillitis as the potential risk factors of actinomycosis. Upon examination of material collected through the course of tonsillectomy, the patient was diagnosed with actinomycosis of the left palatine tonsil. Despite the introduction of antibiotic therapy, initial progression was noted with the appearance of numerous, hypodense changes in the liver and the spleen, which regressed during further antibiotic treatment. According to our team's knowledge, this is the first described case of a patient with actinomycosis occurring simultaneously in the cervico-facial and abdominal area. The unusual localization and potential dissemination of actinomycosis should be considered in clinical practice.


Subject(s)
Actinomycosis , Tonsillitis , Humans , Female , Adult , Actinomycosis/diagnosis , Actinomycosis/drug therapy , Tonsillitis/microbiology , Tonsillitis/drug therapy , Tonsillitis/diagnosis , Anti-Bacterial Agents/therapeutic use , Actinomycosis, Cervicofacial/diagnosis , Actinomycosis, Cervicofacial/drug therapy , Abdomen
5.
Pediatr Infect Dis J ; 43(8): 743-747, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-38564739

ABSTRACT

BACKGROUND: Pediatric actinomycosis studies are limited to case reports or small case series. In this retrospective cohort study, we aimed to describe characteristics of skin and soft tissue actinomycosis in adolescents and children. METHODS: We conducted the study from January 2019 to December 2022, including patients ≤21 years of age with at least 1-year follow-up data. All clinical cultures obtained under sterile conditions with Actinomyces growth were included. RESULTS: One hundred four patients met inclusion criteria; median age 19 (interquartile range: 17-20) years, 68.3% female, 46.2% Black and 47.1% Hispanic. The median antibiotic treatment duration was 10 (7-10) days, and majority of patients received treatment with non-first-line Actinomyces antibiotics. Infectious disease consultation was requested for only 7 patients during their initial skin and soft tissue actinomycosis treatment. One-third of the patients with skin and soft tissue actinomycosis had documented recurrence within a median of 10 (interquartile range: 6-16) months of the initial episode. Monobacterial culture growth (85.7% vs. 63.8%, P = 0.02), patients with body mass index >25 (75% vs. 52.6%, P = 0.04) and patients with prior abscess in the same area (18.8% vs. 51.4%, P = 0.001) were significantly higher in patients with recurrent actinomycosis compared to the nonrecurrent group. In a univariate logistic regression model, they were found to be significantly associated with recurrence; monobacterial growth [odds ratio (OR): 3.4; 95% confidence interval (CI): 1.2-9.9], body mass index >25 (OR: 2.7; 95% CI, 1.1-7.0) and prior abscess (OR: 4.6; 95% CI: 1.9-11.2). CONCLUSIONS: Our study results highlight the importance of considering Actinomyces species in skin and soft tissue infections, especially in recurrent ones, and risk factors for recurrence. Suboptimal antibiotic utilization, very low numbers of consultations with infectious diseases and high recurrence rate suggest that providers should be informed and updated regarding this rare but hard-to-treat infection.


Subject(s)
Actinomyces , Actinomycosis , Anti-Bacterial Agents , Soft Tissue Infections , Humans , Adolescent , Female , Male , Actinomycosis/drug therapy , Actinomycosis/microbiology , Retrospective Studies , Anti-Bacterial Agents/therapeutic use , Child , Soft Tissue Infections/microbiology , Soft Tissue Infections/drug therapy , Soft Tissue Infections/epidemiology , Actinomyces/isolation & purification , Young Adult , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/epidemiology , Recurrence , Child, Preschool
6.
Pediatrics ; 153(5)2024 May 01.
Article in English | MEDLINE | ID: mdl-38655638

ABSTRACT

Esophageal stenosis can cause vomiting or dysphagia in children and is commonly treated with esophageal balloon dilation. However, surgery may be required if the stenosis does not respond to dilation. Although esophageal actinomycosis can cause severe esophageal strictures and be refractory to balloon dilation, it has been reported to respond effectively to antimicrobial therapy in adults. However, the course of the disease and appropriate treatment strategies in children are not well understood. We present a case of a previously healthy 2-year-old boy diagnosed with esophageal stenosis because of actinomycosis. The patient was treated with intravenous penicillin G, followed by oral amoxicillin for 8 weeks and 6 months, respectively. After completion of the antimicrobial treatment, the patient showed improvement in symptoms and endoscopic findings. At the 1-year follow-up, the patient showed consistent weight gain and normal growth without further intervention. This case highlights the importance of considering esophageal actinomycosis as a potential cause of esophageal stenosis in children and the potential effectiveness of antimicrobial therapy in avoiding surgical intervention.


Subject(s)
Actinomycosis , Amoxicillin , Esophageal Stenosis , Humans , Male , Esophageal Stenosis/etiology , Esophageal Stenosis/drug therapy , Actinomycosis/drug therapy , Actinomycosis/diagnosis , Actinomycosis/complications , Child, Preschool , Amoxicillin/therapeutic use , Amoxicillin/administration & dosage , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Penicillin G/therapeutic use , Penicillin G/administration & dosage
8.
Indian J Med Microbiol ; 49: 100573, 2024.
Article in English | MEDLINE | ID: mdl-38556249

ABSTRACT

Actinomycosis is a rare infection caused by Actinomyces spp. Of all actinomycosis infections, only 5% of Hepatic Actinomycosis (HA) infection has been reported. This disease is often misdiagnosed as a malignancy. This case report presents a 45-year-old woman with diabetes, initially suspected of intrahepatic cholangiocarcinoma, but after careful tissue staining, we found the results supported HA infection.


Subject(s)
Actinomyces , Actinomycosis , Humans , Actinomycosis/diagnosis , Actinomycosis/microbiology , Actinomycosis/pathology , Actinomycosis/drug therapy , Female , Middle Aged , Actinomyces/isolation & purification , Liver/pathology , Liver/microbiology , Liver Diseases/microbiology , Liver Diseases/diagnosis , Liver Diseases/pathology , Histocytochemistry , Tomography, X-Ray Computed
9.
Infect Disord Drug Targets ; 24(6): e300124226501, 2024.
Article in English | MEDLINE | ID: mdl-38299277

ABSTRACT

BACKGROUND: Actinomyces species are commensal oral cavity flora that can cause jaw osteomyelitis. Osteomyelitis of the jaw by Actinomyces is rare, and its presentation can be confused with many different pathologies. CASE PRESENTATION: This is the case of a 61-year-old female with breast cancer and on chemotherapy as well as non-invasive carcinoma of the tongue who initially presented to the dentist with white spots in the right mandible near the incisors associated with right mandible pain and swelling. Actinomyces-induced osteomyelitis of the mandible was diagnosed. The patient was treated with penicillin V for 6 weeks along with a course of hyperbaric oxygen therapy, which resulted in the complete resolution of the infection. CONCLUSION: In summary, jaw osteomyelitis caused by Actinomyces should always be part of the differential diagnosis; as these organisms are commensal flora. The symptoms manifested are non-specific, and such a diagnosis could be easily missed, resulting in delay of care and disease progression.


Subject(s)
Actinomyces , Actinomycosis , Osteomyelitis , Humans , Osteomyelitis/microbiology , Osteomyelitis/diagnosis , Osteomyelitis/drug therapy , Female , Middle Aged , Actinomycosis/diagnosis , Actinomycosis/microbiology , Actinomycosis/drug therapy , Actinomycosis/complications , Actinomyces/isolation & purification , Anti-Bacterial Agents/therapeutic use , Mandible/microbiology , Hyperbaric Oxygenation , Diagnosis, Differential , Mandibular Diseases/microbiology , Mandibular Diseases/drug therapy , Breast Neoplasms/complications , Breast Neoplasms/drug therapy
10.
Dermatologie (Heidelb) ; 75(6): 492-495, 2024 Jun.
Article in German | MEDLINE | ID: mdl-38361042

ABSTRACT

We report a 77-year-old man with a skin abscess caused by Actinomyces radingae. Targeted antibiotic therapy with amoxicillin/clavulanic acid for 6 weeks resulted in clearing of the infection. A. radingae is a rare pathogenic agent of skin and soft tissue infections. As with other Actinomyces infections, the early identification of the pathogen and specific antibiotic therapy is crucial for successful resolution of the infection because of the chronic course and the long treatment time needed. Usually, A. radingae is sensitive to ß­lactam antibiotics.


Subject(s)
Abscess , Actinomyces , Actinomycosis , Anti-Bacterial Agents , Skin Diseases, Bacterial , Humans , Male , Aged , Abscess/microbiology , Abscess/drug therapy , Abscess/diagnosis , Actinomycosis/drug therapy , Actinomycosis/diagnosis , Actinomycosis/microbiology , Actinomycosis/pathology , Actinomyces/isolation & purification , Anti-Bacterial Agents/therapeutic use , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/diagnosis , Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Treatment Outcome
11.
Am J Trop Med Hyg ; 110(3): 504-508, 2024 Mar 06.
Article in English | MEDLINE | ID: mdl-38295417

ABSTRACT

Actinomycosis is an uncommon infection caused by Actinomyces species, and the diagnosis is often challenging owing to low prevalence and diverse clinical manifestations. Pericardial involvement of actinomycosis is particularly rare. Here, we present a case of a 79-year-old man who initially complained of exertional dyspnea, orthopnea, and decreased urine amount. There was no fever, chest pain, or productive cough. Physical examination was remarkable for decreased breath sounds at the left lower lung field. Poor dental hygiene and a firm, well-defined mass without discharge over the hard palate were noted. Echocardiography revealed reduced ejection fraction of the left ventricle, global hypokinesia, and thickened pericardium (> 5 mm) with a small amount of pericardial effusion. On admission, the patient underwent diagnostic thoracentesis, and the results suggested an exudate. However, bacterial and fungal cultures were all negative. There was no malignant cell by cytology. Computed tomography revealed contrast-enhanced pericardial nodular masses. Video-assisted thoracoscopic pericardial biopsy was performed. Histopathology confirmed actinomycosis with chronic abscess formation, and a tissue culture yielded Aggregatibacter actinomycetemcomitans. The symptoms resolved with administration of clindamycin for 6 months. This case highlights the challenge in the diagnosis of cardiac actinomycosis, the potential role of concomitant microorganisms as diagnostic clues, and the favorable clinical response achieved with appropriate antibiotic treatment.


Subject(s)
Actinomycosis , Oral Hygiene , Male , Humans , Aged , Actinomycosis/diagnosis , Actinomycosis/drug therapy , Actinomyces , Anti-Bacterial Agents/therapeutic use , Pericardium/pathology
12.
BMC Infect Dis ; 24(1): 109, 2024 Jan 20.
Article in English | MEDLINE | ID: mdl-38245682

ABSTRACT

BACKGROUND: Actinomyces turicensis is rarely responsible of clinically relevant infections in human. Infection is often misdiagnosed as malignancy, tuberculosis, or nocardiosis, therefore delaying the correct identification and treatment. Here we report a case of a 55-year-old immunocompetent adult with brain abscess caused by A. turicensis. A systematic review of A. turicensis infections was performed. METHODS: A systematic review of the literature was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The databases MEDLINE, Embase, Web of Science, CINAHL, Clinicaltrials.gov and Canadian Agency for Drugs and Technology in Health (CADTH) were searched for all relevant literature. RESULTS: Search identified 47 eligible records, for a total of 67 patients. A. turicensis infection was most frequently reported in the anogenital area (n = 21), causing acute bacterial skin and skin structure infections (ABSSSI) including Fournier's gangrene (n = 12), pulmonary infections (n = 8), gynecological infections (n = 6), cervicofacial district infections (n = 5), intrabdominal or breast infections (n = 8), urinary tract infections (n = 3), vertebral column infections (n = 2) central nervous system infections (n = 2), endocarditis (n = 1). Infections were mostly presenting as abscesses (n = 36), with or without concomitant bacteremia (n = 7). Fever and local signs of inflammation were present in over 60% of the cases. Treatment usually involved surgical drainage followed by antibiotic therapy (n = 51). Antimicrobial treatments most frequently included amoxicillin (+clavulanate), ampicillin/sulbactam, metronidazole or cephalosporins. Eighty-nine percent of the patients underwent a full recovery. Two fatal cases were reported. CONCLUSIONS: To the best of our knowledge, we hereby present the first case of a brain abscess caused by A. turicensis and P. mirabilis. Brain involvement by A. turicensis is rare and may result from hematogenous spread or by dissemination of a contiguous infection. The infection might be difficult to diagnose and therefore treatment may be delayed. Nevertheless, the pathogen is often readily treatable. Diagnosis of actinomycosis is challenging and requires prompt microbiological identification. Surgical excision and drainage and antibiotic treatment usually allow for full recovery.


Subject(s)
Actinomycosis , Brain Abscess , Adult , Humans , Middle Aged , Actinomyces , Actinomycosis/diagnosis , Actinomycosis/drug therapy , Anti-Bacterial Agents/therapeutic use , Brain Abscess/diagnosis , Brain Abscess/drug therapy , Canada
13.
BMJ Case Rep ; 17(1)2024 Jan 09.
Article in English | MEDLINE | ID: mdl-38195185

ABSTRACT

A man in his 50s, with a history of night sweats and weight loss, presented acutely with dyspnoea and chest pain. Imaging revealed right middle lobe consolidation and a large pericardial effusion. The diagnosis of actinomycosis was made using endobronchial ultrasound-guided sampling from the pericardial effusion. An orthopantomogram demonstrated that the source was a large cavity in the left lower wisdom tooth. This tooth was extracted before the completion of his antibiotic course, and the patient made a full recovery. Cardiac actinomycosis is rare, and there are few case reports describing endobronchial ultrasound-guided sampling of pericardial fluid.


Subject(s)
Actinomycosis , Pericardial Effusion , Humans , Male , Actinomycosis/diagnostic imaging , Actinomycosis/drug therapy , Anti-Bacterial Agents/therapeutic use , Chest Pain/etiology , Pericardial Effusion/diagnostic imaging , Pericardium , Middle Aged
18.
J Investig Med High Impact Case Rep ; 11: 23247096231217823, 2023.
Article in English | MEDLINE | ID: mdl-38102073

ABSTRACT

Individuals with COVID-19 are prone to a variety of infections due to immune dysregulation. The present report presents a case of actinomycotic infection in the maxillary bone and sinus region in a patient with a history of COVID-19. This case report highlights the importance of considering bacterial infections including actinomycosis when encountering destructive lesions resembling more prevalent fungal infections due to different therapeutic medication protocols. In addition, a literature review of the existing reports of similar post-COVID-19 actinomycotic infection is presented.


Subject(s)
Actinomycosis , COVID-19 , Maxillary Sinusitis , Humans , Actinomycosis/diagnosis , Actinomycosis/drug therapy , Actinomycosis/microbiology , COVID-19/complications , Maxillary Sinusitis/complications , Maxillary Sinusitis/microbiology
19.
Odovtos (En línea) ; 25(3): 10-17, Sep.-Dec. 2023. graf
Article in English | LILACS, BBO - Dentistry , SaludCR | ID: biblio-1529065

ABSTRACT

Abstract Osteomyelitis is defined as the inflammation of the either medullary, cortical, or cancellous bone, including nerves and blood vessels, causing necrosis and bone sequestrum formation; this condition has become a rare pathology, and odontogenic infections are considered the most frequent causal factor. This case shows a patient with bi-maxillary osteomyelitis caused by Actinomyces spp, which was worsened for severe COVID-19 infection. Patient was submitted at surgery as, amplified total bilateral maxillectomy through the surgical technique Weber-Fergusson, and prolonged use of combination of antibiotics, achieved a good recovery. Two years later follow- up, the patient no show imaging or clinical evidence of the infection of osteomyelitis. The present case shows an interesting relationship between a rare infection and its association with COVID-19.


Resumen La osteomielitis se define como la inflamación del hueso medular, cortical o esponjoso, incluyendo nervios y vasos sanguíneos, causando necrosis y formación de secuestro óseo; esta condición es una patología rara, y las infecciones odontogénicas son consideradas como el factor causal más frecuente. En este caso, se muestra un paciente con osteomielitis bi-maxilar causada por Actinomyces spp, la cual empeoró por la infección de COVID-19 severo. El paciente fue sometido a una cirugía, maxilectomía bilateral total amplificada, a través de la técnica quirúrgica de Weber- Fergusson, y el uso prolongado de una combinación de antibióticos, logrando una buena recuperación. A los 2 años de seguimiento, el paciente no mostró evidencia clínica o imagenológica de la infección de osteomielitis. El presente caso muestra una interesante relación entre una infección rara y su asociación con COVID-19.


Subject(s)
Humans , Male , Middle Aged , Osteomyelitis/diagnostic imaging , Actinomycosis/drug therapy , Surgery, Oral , COVID-19
20.
Am J Case Rep ; 24: e941498, 2023 Nov 03.
Article in English | MEDLINE | ID: mdl-37919883

ABSTRACT

BACKGROUND Actinomyces, a filamentous, branching, anaerobic gram-positive bacillus, typically found as a commensal organism in the oral cavity, can lead to rare chronic bacterial infections in various anatomical regions. Chest wall involvement represents an uncommon presentation, posing significant diagnostic challenges. This report focuses on the case of a 13-year-old boy presenting with chest wall actinomycetoma that closely resembled Ewing sarcoma on imaging. CASE REPORT We present the case of a 13-year-old male with no previous medical history who presented to the Emergency Department with progressive left-sided chest pain following a sports-related fall. Physical examination revealed mild swelling and tenderness on the left anterior chest wall. A chest computed tomography (CT) scan revealed a large tumor involving the lower left chest wall, suggesting Ewing sarcoma. However, a histopathological examination unexpectedly confirmed actinomycosis of the chest wall. Intravenous penicillin G was promptly initiated for 4 weeks. A follow-up CT scan after 4 weeks of therapy demonstrated a significant response with notable reduction in the size of the chest wall mass. The patient then continued with maintenance therapy using oral amoxicillin for 12 months. Throughout this period, complete resolution of the chest wall mass occurred, with no significant adverse events or complications observed. CONCLUSIONS This case highlights the importance of considering uncommon differential diagnoses like chest wall actinomycosis in patients presenting with chest wall masses. The diagnostic complexities associated with this rare condition emphasize the need for a comprehensive evaluation strategy, incorporating histopathological examination and imaging.


Subject(s)
Actinomycosis , Sarcoma, Ewing , Thoracic Wall , Male , Humans , Adolescent , Sarcoma, Ewing/diagnostic imaging , Sarcoma, Ewing/complications , Thoracic Wall/diagnostic imaging , Actinomycosis/diagnostic imaging , Actinomycosis/drug therapy , Actinomyces , Amoxicillin
SELECTION OF CITATIONS
SEARCH DETAIL